Showing all 8 results
Amoxicillin & Potassium Clavulanate Dispersible Tablets
FreeProduct Composition & Strength
We supply this product in the globally standardized 7:1 ratio, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive Clavulanate.
Active Ingredient Strength Primary Clinical Function Amoxicillin (as Trihydrate) USP/BP 200 mg / 400 mg The Growth Inhibitor: Destroys the bacterial cell wall across a broad range of pathogens. Potassium Clavulanate USP/BP 28.5 mg / 57 mg The Resistance Shield: Neutralizes bacterial enzymes, allowing Amoxicillin to function. Excipients Sweetened Matrix Pediatric-Friendly System: Engineered with pleasant fruit flavors to ensure 100% child compliance. Amoxycillin & Potassium Clavulanate Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Dry Powder for Injection in glass vials. The ratio is critically balanced (usually 5:1) for optimal pharmacokinetics in intravenous use.
Strength Variant Amoxicillin Content (as Sodium) Clavulanic Acid Content (as Potassium) Target Patient 1.2 g Vial 1000 mg (1 g) 200 mg Adults (Severe) 600 mg Vial 500 mg 100 mg Adults / Children 300 mg Vial 250 mg 50 mg Pediatric 150 mg Vial 125 mg 25 mg Infants *Pack Sizes: Tray of 1 Vial or Box of 1/10 Vials with Water for Injection (WFI).
Amoxycillin and Clavulanic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, ultra-low moisture Alu-Alu blister strips (often containing integrated desiccants) to ensure the absolute stability of the incredibly hygroscopic Clavulanate salt.
Active Ingredient Strength Primary Clinical Function Amoxicillin Trihydrate USP/Ph.Eur.
Potassium Clavulanate USP/Ph.Eur.500 mg
125 mg
(Total: 625 mg)Standard Adult Dose: Therapy for moderate RTIs, dental infections, and skin infections. Amoxicillin Trihydrate USP/Ph.Eur.
Potassium Clavulanate USP/Ph.Eur.875 mg
125 mg
(Total: 1000 mg)High-Dose Adult Therapy: Aggressive intervention for severe pneumonia, severe sinus infections, and bite wounds. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Moisture Scavenger (Engineered for immediate gastric dissolution) *Pack Sizes: 1×6 or 1×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-7 day acute antibiotic regimens).
Cefixime & Potassium Clavulanate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative bacilli and Enteric pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefixime and Clavulanic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative bacilli and Enteric pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefpodoxime & Clavulanic acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative and Gram-positive pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefpodoxime & Potassium Clavulanate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative and Gram-positive pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation.
